12-57064170-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001130963.2(NEMP1):c.655G>A(p.Val219Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000517 in 1,604,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001130963.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEMP1 | NM_001130963.2 | c.655G>A | p.Val219Ile | missense_variant | 6/9 | ENST00000300128.9 | NP_001124435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEMP1 | ENST00000300128.9 | c.655G>A | p.Val219Ile | missense_variant | 6/9 | 1 | NM_001130963.2 | ENSP00000300128.4 | ||
NEMP1 | ENST00000379391.7 | c.436G>A | p.Val146Ile | missense_variant | 5/8 | 1 | ENSP00000368701.3 | |||
NEMP1 | ENST00000554340.1 | n.*160+476G>A | intron_variant | 1 | ENSP00000452391.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000414 AC: 10AN: 241354Hom.: 0 AF XY: 0.0000305 AC XY: 4AN XY: 130980
GnomAD4 exome AF: 0.0000537 AC: 78AN: 1452560Hom.: 0 Cov.: 29 AF XY: 0.0000553 AC XY: 40AN XY: 722894
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74238
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at